Item 5.07 Submission of Matters to a Vote of Security Holders.

Solid Biosciences Inc. (the "Company") held its Annual Meeting of Stockholders on June 7, 2022 (the "Annual Meeting") to consider and vote upon the matters listed below. The following is a summary of the matters voted on at the Annual Meeting.



    1.   The Company's stockholders elected Robert Huffines, Sukumar Nagendran and
         Rajeev Shah as Class I directors to serve until the 2025 Annual Meeting
         of Stockholders, each director to hold office until his successor has
         been duly appointed and qualified. The results of the stockholders' vote
         with respect to the election of such Class I directors were as follows:



                                     Votes        Votes         Broker
                     Votes For      Against     Abstaining    Non-Votes
Robert Huffines      65,983,358    4,725,294     128,485      16,703,177
Sukumar Nagendran    65,958,891    4,751,267     126,979      16,703,177
Rajeev Shah          65,969,209    4,739,948     127,980      16,703,177



    2.   The Company's stockholders ratified the appointment of
         PricewaterhouseCoopers LLP as the Company's independent registered public
         accounting firm for the fiscal year ending December 31, 2022. The results
         of the stockholders' vote with respect to such ratification were as
         follows:



Votes For    Votes Against   Votes Abstaining   Broker Non-Votes
87,285,653      226,917           27,744               -



    3.   The Company's stockholders approved an amendment to the Company's
         certificate of incorporation to effect a reverse stock split at a ratio
         of not less than 1-for-5 and not greater than 1-for-15, with the exact
         ratio to be set within that range at the discretion of the Company's
         Board of Directors prior to the Company's 2023 Annual Meeting of
         Stockholders without further approval or authorization of the Company's
         stockholders and with the Board of Directors able to elect to abandon
         such proposed amendment and not effect the reverse stock split authorized
         by stockholders, in its sole discretion, and, in connection therewith, to
         decrease the number of authorized shares of the Company's common stock on
         a basis proportional to the reverse stock split ratio (the "Reverse Stock
         Split Proposal"). The results of the stockholders' vote with respect to
         the Reserve Stock Split Proposal were as follows:



Votes For    Votes Against   Votes Abstaining   Broker Non-Votes
86,259,460     1,145,377         135,477               -



    4.   The Company's stockholders approved an amendment to the Company's
         certificate of incorporation to set the number of authorized shares of
         the Company's common stock at a number determined by calculating the
         product of 300,000,000 multiplied by three times (3x) the reverse stock
         split ratio, subject to approval by the Company's stockholders of the
         Reverse Stock Split Proposal and the Company's implementation of a
         reverse stock split (the "Authorized Shares Proposal"). The results of
         the stockholders' vote with respect to the Authorized Shares Proposal
         were as follows:



Votes For    Votes Against   Votes Abstaining   Broker Non-Votes
75,102,793    12,303,933         133,588               -

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses